GSK-2807

GSK2807 is a potent and selective, SAM-competitive inhibitor of SMYD3 (Ki = 14 nM). GSK2807 bridges the gap between the SAM-binding pocket and the substrate lysine tunnel of SMYD3. GSK2807 may be useful for cancer treatment.


Cat. No.: EX-A2734	Purity: >97%

	Chemical structure of GSK-2807

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	Get quote	In-stock
500mg	Get quote	In-stock
1g	Get quote	In-stock
5g	Get quote

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


CAS No.	2245255-65-4
Purity	>97%
Formula	C19H32N8O5
Mol Weight	452.508
Appearance	Solid powder
Solubility	Soluble in DMSO/water
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Van Aller GS, et al. Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets. Structure. 2016 May 3;24(5):774-781. [2]. Kaniskan HÜ, et al. Inhibitors of Protein Methyltransferases and Demethylases. Chem Rev. 2018 Feb 14;118(3):989-1068.
CoA	CoA of GSK-2807

Smiles:	NC1=C2C(N([C@H]3[C@H](O)[C@H](O)[C@@H](CN(CC[C@H](N)C(O)=O)CCCN(C)C)O3)C=N2)=NC=N1


		Search